TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia

@article{Bhowmick2004TGFSI,
  title={TGF-{\ss} Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia},
  author={Neil A. Bhowmick and Anna Chytil and David Plieth and Agnieszka E. Gorska and Nancy Dumont and Scott B. Shappell and M. Kay Washington and Eric G. Neilson and Harold L Moses},
  journal={Science},
  year={2004},
  volume={303},
  pages={848 - 851}
}
Stromal cells can have a significant impact on the carcinogenic process in adjacent epithelia. The role of transforming growth factor–β (TGF-β) signaling in such epithelial-mesenchymal interactions was determined by conditional inactivation of the TGF-β type II receptor gene in mouse fibroblasts (Tgfbr2fspKO). The loss of TGF-β responsiveness in fibroblasts resulted in intraepithelial neoplasia in prostate and invasive squamous cell carcinoma of the forestomach, both associated with an… 

TGF-β Signaling in Fibroblastic Cells and Oncogenesis

Reports suggest stromal TGF-β responsivity is involved in the initiation, progression and metastasis of cancer in a tissue specific manner.

TGF-β Signaling in Fibroblasts Regulates Tumor Initiation and Progression in Adjacent Epithelia

The literature suggests that the T GF-β response by fibroblasts and fibroblast production of TGF-β ligands can suppress or promote adjacent carcinoma progression depending upon the context of stimulation.

TGF-β Signaling Alterations in Neoplastic and Stromal Cells

Transforming growth factor beta (TGF-β) plays an central role in cell homeostasis and inherited mutations in the TGFB1 gene cause Camurati-Engelmann disease, a condition characterized by hyperostosis

Cancer-Associated Fibroblasts and the Role of TGF-β

Experimental evidence on the important role of TGF-β in fibroblast-epithelial interaction, as obtained from in vitro studies and from animal models is presented.

TGF-β and Stromal Influences Over Local Tumor Invasion

It is likely that a better characterization of the role of TGF-β in the crosstalk between stromal and malignant cells will unravel novel therapeutic options and promote tumor growth at late stages of carcinogenesis.

Role of the Adjacent Stroma Cells in Prostate Cancer Development and Progression: Synergy between TGF-β and IGF Signaling

A continuous input from TGF-β and IGF in the tumor microenvironment will result in cancer progression and understanding of these events can help prevention, diagnosis, and therapy of prostate cancer.

Transforming Growth Factor-β: An Agent of Change in the Tumor Microenvironment

How a core property of TGF-β, namely its ability to change cell differentiation, leads to the transition of epithelial cells, endothelial cells and fibroblasts to a myofibroblastoid phenotype, changes differentiation and polarization of immune cells, and induces metabolic reprogramming of cells are discussed.

Altered TGF-β signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis.

In vivo, tissue recombination of fibroblasts overexpressing TGF-β1 and SDF1/CXCL12 not only induced transformation of BPH1 cells, but also promoted a robust growth of highly invasive cells, similar to effects produced by CAFs.

BMP7 Signaling in TGFBR2-Deficient Stromal Cells Provokes Epithelial Carcinogenesis

These findings reveal a complex cross-talk between epithelial cells and the stroma, wherein Smad4 is required to elicit squamous cell carcinomas in the forestomach of mice with TGFBR2-deficient stromal cells.

Stromal Modulators of TGF-β in Cancer

The present review highlights the present understanding of how stroma modulates TGF-β activity in human cancers and highlights the need to understand the complex interplay between the T GF-β signaling network and these stromal proteins.
...

References

SHOWING 1-10 OF 20 REFERENCES

TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells.

It is reported here that TGF-beta1 brings about changes in Ras-transformed cells but not in normal cells, which are operative during in vivo tumorigenesis and, as in wound healing processes, dependent on epithelial-stromal interactions.

Signal Transduction by the TGF-β Superfamily

Recent insights have revealed how SMAD proteins themselves are regulated and how appropriate subcellular localization of SMADs and TGF-β transmembrane receptors is controlled.

Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.

There are mutual interactions between carcinoma cells and fibroblasts: IL-1, bFGF, and platelet-derived growth factor derived from tumor cells play a role in inducing HGF expression in stromal fibro Blasts, whereas fibroblast-derived HGF, in turn, leads to invasive growth in carcinoma Cells.

Binding of transforming growth factor-beta to cell surface proteins varies with cell type.

Analysis indicated that binding to the high Mr proteoglycan is not necessary for TGF beta 1 induced regulation of DNA, collagen and fibronectin synthesis, change in cell morphology, or reorganization of the actin cytoskeleton, and it is proposed that the lower Mr components are the active receptors mediating these events.

Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction.

This review highlights the current knowledge of tumor cell stromal interactions in the mammary gland with particular emphasis on cellular origins and functional phenotypes and on culture systems developed to dissect individual aspects of cell-cell and cell-extracellular matrix interactions.

Possible involvement of p21/waf1 in the growth inhibition of HepG2 cells induced by hepatocyte growth factor

A comparative study of HGF‐mediated signal transduction events between two opposite responding types of human hepatoblastoma cell lines suggests that sustained induction of p21/waf1 mediates growth inhibition in HepG2 in the presence of H GF.

Intrauterine transplantation of rat basal cell carcinoma as a model for reconversion of malignant to benign growth.

The results lend support to the thesis that the epithelial cells of basal cell carcinomas are stimulated to continuous neoplastic proliferation, are prevented from maturing by stimuli from specific tumor stroma, and will express their differentiation potential when exposed to normal stroma.

Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo.

Both TGF beta 1 and beta 2 transcripts are seen in regions actively undergoing cardiac septation and valve formation, suggesting some interaction of these growth factors in this developmental process.

Identification and characterization of a fibroblast marker: FSP1

Experiments in which the in vitro overexpression of FSP1 cDNA in tubular epithelium is accompanied by conversion to a mesenchymal phenotype are observed, as characterized by a more stellate and elongated fibroblast- like appearance, a reduction in cytokeratin, and new expression of vimentin.

Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts.

The conditional reduction of tissue fibroblasts using the coding sequence for herpesvirus thymidine kinase (DeltaTK) put under the control of a cell-specific promoter from the gene encoding fibroblast-specific protein 1 (FSP1) is reported, conveying a proof of principle regarding the importance of FSP1(+) fibro Blasts in fibrosis as well as providing a new approach to treating the relentless scarification of tissue.